Skip to main content
Department of Pediatrics Department of Pediatrics
  1. HOME
  2. Divisions
  3. Infectious Diseases
  4. Faculty
  5. Chris Cannavino

Chris Cannavino

ELLOWSHIP DIRECTOR ASSOCIATE CLINICAL PROFESSOR

Education

  • Undergraduate: University of California at Los Angeles, B.S. Psychobiology
  • Medical School: University of California at San Diego School of Medicine, M.D.
  • Residency: University of California at San Diego, Pediatric Residency Program
  • Chief Residency: University of California at San Diego, Pediatric Residency Program
Fellowships:
  • University of California at San Diego, Pediatric Infectious Diseases
  • Rady Children’s Hospital San Diego, Pediatric Hospital Medicine
Leadership Roles:
  • Director, UCSD Pediatric Infectious Disease Fellowship Program
  • Associate Director, UCSD Pediatric Residency Program
  • Director, Master Clinician Program, UCSD School of Medicine
  • Director, Pediatric Medical Student Education, UCSD School of Medicine
Awards
  • UCSD Pediatric Residency Program Teaching Award Fellow/Attending of the Year, 2008
  • UCSD Pediatric Residency Program Teaching Award Attending of the Year, 2010
  • National Center of Leadership in Academic Medicine, UCSD School of Medicine, 2011
  • Physician Leadership Academy Rady Children’s Hospital San Diego, 2014
  • Physician Award of Excellence: Career Excellence in Teaching Award, Rady Children’s Hospital San Diego, 2016
  • Master Clinician, UCSD School of Medicine, 2016-Present
Dr. Cannavino’s clinical and translational research interests focus on two areas: (1) clinical treatment algorithms and (2) anti-infective agent development. He is the principle investigator or co-PI on clinical research projects involving the development of clinical decision rules for a variety of infections in the pediatric population. He is also involved in studies examining the utility of novel rapid diagnostic testing methods for infections, using cell-free pathogen next generation sequencing technology. He is involved in the development of antibacterial, antiviral and antifungal agents; with phase I, II and III clinical studies. Specifically, he is the PI or sub-investigator for a number of studies examining the safety, tolerability, pharmacokinetics, and efficacy of antiinfectives in the pediatric population. He also serves on advisory boards and is involved in the design of such studies.
UCSD Profile for most updated list of publications